▶ 調査レポート

中国のオキシトシン市場

• 英文タイトル:China Oxytocin Market Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。中国のオキシトシン市場 / China Oxytocin Market Status and Forecast 2020-2026 / MRC9831005資料のイメージです。• レポートコード:MRC9831005
• 出版社/出版日:QYResearch / 2020年5月
• レポート形態:英文、PDF、85ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥301,600 (USD2,900)▷ お問い合わせ
  Enterprise License¥603,200 (USD5,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要

Oxytocin market is segmented by region, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Oxytocin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
For China market, this report focuses on the Oxytocin market size by players, by Type, and by Application, for the period 2015-2026. The key players include the players which play important roles in China.
The Key manufacturers that are operating in the China Oxytocin market are:
 Hybio Pharmaceutical
 Ningbo Renjian Pharmaceutical Group
 Nanjing Xinbai Pharmaceutical
 Shanghai Harvest Pharmaceutical
 Suzhou Tianji Bio-Pharmaceutical
 Chengdu Hepatunn
 SPH NO.1 Biochemical & Pharmaceutical
 Shanghai Ceneral Pharmaceutical
 Anhui Hongye Pharmaceutical
 Tianjin Biochem Pharmaceutical

Segment by Type
 Oxytocin 10 IU/ml
 Oxytocin 5 IU/ml

Segment by Application
 For Baby Born
 For Comestic
 Others

Segment by Region
 East China
 South China
 North China
 Central China
 West China
 Other Regions

レポート目次

1 MARKET OVERVIEW
1.1 Oxytocin Product Introduction and Study Scope
1.2 Market by Type
1.2.1 China Oxytocin Market Size Growth Rate by Type
1.2.2 Oxytocin 10 IU/ml
1.2.3 Oxytocin 5 IU/ml
1.3 Market by Application
1.3.1 China Oxytocin Sales Growth Rate by Application
1.3.2 For Baby Born
1.3.3 For Comestic
1.3.4 Others
1.4 China Oxytocin Market Size, Status and Forecast, 2015-2026
1.4.1 China Oxytocin Revenue, Status and Forecast, 2015-2026
1.4.2 China Oxytocin Sales, Status and Forecast, 2015-2026
2 CHINA OXYTOCIN COMPETITOR LANDSCAPE BY PLAYERS
2.1 China Oxytocin Sales and Revenue by Manufacturers
2.1.1 China Oxytocin Sales by Manufacturer (2015-2020)
2.1.2 China Oxytocin Revenue by Manufacturer (2015-2020)
2.1.3 Key Oxytocin Manufacturers Covered: Ranking by Revenue
2.1.4 China Oxytocin Price by Manufacturer (2015-2020)
2.2 China Key Manufacturers Oxytocin Commercial Sales Date and Manufacturing Base Distribution
2.3 China Oxytocin Market Concentration Ratio Analysis
2.3.1 China Top 10 and Top 5 Companies by Oxytocin Revenue in 2019
2.3.2 China Oxytocin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Primary Interviews with Key Oxytocin Players (Opinion Leaders)
3 CHINA OXYTOCIN MARKET SIZE BY REGION
3.1 Oxytocin Market Size by Region: 2015-2026
3.1.1 China Oxytocin Sales by Region: 2015-2020
3.1.2 China Oxytocin Sales Forecast by Region (2021-2026)
3.1.3 China Oxytocin Revenue by Region: 2015-2020
3.1.4 China Oxytocin Revenue Forecast by Region (2021-2026)
3.2 East China Oxytocin Sales and Revenue Growth (2015-2026)
3.3 South China Oxytocin Sales and Revenue Growth (2015-2026)
3.4 North China Oxytocin Sales and Revenue Growth (2015-2026)
3.5 Central China Oxytocin Sales and Revenue Growth (2015-2026)
3.6 West China Oxytocin Sales and Revenue Growth (2015-2026)
4 CHINA MAJOR OXYTOCIN MANUFACTURERS PROFILE
4.1 Hybio Pharmaceutical
4.1.1 Hybio Pharmaceutical Corporation Information
4.1.2 Hybio Pharmaceutical Oxytocin Product Description
4.1.3 Hybio Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2015-2020)
4.1.4 Hybio Pharmaceutical Overview and Its Total Revenue
4.1.5 Hybio Pharmaceutical Recent Development
4.2 Ningbo Renjian Pharmaceutical Group
4.2.1 Ningbo Renjian Pharmaceutical Group Corporation Information
4.2.2 Ningbo Renjian Pharmaceutical Group Oxytocin Product Description
4.2.3 Ningbo Renjian Pharmaceutical Group Oxytocin Sales, Price, Revenue and Gross Margin (2015-2020)
4.2.4 Ningbo Renjian Pharmaceutical Group Overview and Its Total Revenue
4.2.5 Ningbo Renjian Pharmaceutical Group Recent Development
4.3 Nanjing Xinbai Pharmaceutical
4.3.1 Nanjing Xinbai Pharmaceutical Corporation Information
4.3.2 Nanjing Xinbai Pharmaceutical Oxytocin Product Description
4.3.3 Nanjing Xinbai Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2015-2020)
4.3.4 Nanjing Xinbai Pharmaceutical Overview and Its Total Revenue
4.3.5 Nanjing Xinbai Pharmaceutical Recent Development
4.4 Shanghai Harvest Pharmaceutical
4.4.1 Shanghai Harvest Pharmaceutical Corporation Information
4.4.2 Shanghai Harvest Pharmaceutical Oxytocin Product Description
4.4.3 Shanghai Harvest Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2015-2020)
4.4.4 Shanghai Harvest Pharmaceutical Overview and Its Total Revenue
4.4.5 Shanghai Harvest Pharmaceutical Recent Development
4.5 Suzhou Tianji Bio-Pharmaceutical
4.5.1 Suzhou Tianji Bio-Pharmaceutical Corporation Information
4.5.2 Suzhou Tianji Bio-Pharmaceutical Oxytocin Product Description
4.5.3 Suzhou Tianji Bio-Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2015-2020)
4.5.4 Suzhou Tianji Bio-Pharmaceutical Overview and Its Total Revenue
4.5.5 Suzhou Tianji Bio-Pharmaceutical Recent Development
4.6 Chengdu Hepatunn
4.6.1 Chengdu Hepatunn Corporation Information
4.6.2 Chengdu Hepatunn Oxytocin Product Description
4.6.3 Chengdu Hepatunn Oxytocin Sales, Price, Revenue and Gross Margin (2015-2020)
4.6.4 Chengdu Hepatunn Overview and Its Total Revenue
4.6.5 Chengdu Hepatunn Recent Development
4.7 SPH NO.1 Biochemical & Pharmaceutical
4.7.1 SPH NO.1 Biochemical & Pharmaceutical Corporation Information
4.7.2 SPH NO.1 Biochemical & Pharmaceutical Oxytocin Product Description
4.7.3 SPH NO.1 Biochemical & Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2015-2020)
4.7.4 SPH NO.1 Biochemical & Pharmaceutical Overview and Its Total Revenue
4.7.5 SPH NO.1 Biochemical & Pharmaceutical Recent Development
4.8 Shanghai Ceneral Pharmaceutical
4.8.1 Shanghai Ceneral Pharmaceutical Corporation Information
4.8.2 Shanghai Ceneral Pharmaceutical Oxytocin Product Description
4.8.3 Shanghai Ceneral Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2015-2020)
4.8.4 Shanghai Ceneral Pharmaceutical Overview and Its Total Revenue
4.8.5 Shanghai Ceneral Pharmaceutical Recent Development
4.9 Anhui Hongye Pharmaceutical
4.9.1 Anhui Hongye Pharmaceutical Corporation Information
4.9.2 Anhui Hongye Pharmaceutical Oxytocin Product Description
4.9.3 Anhui Hongye Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2015-2020)
4.9.4 Anhui Hongye Pharmaceutical Overview and Its Total Revenue
4.9.5 Anhui Hongye Pharmaceutical Recent Development
4.10 Tianjin Biochem Pharmaceutical
4.10.1 Tianjin Biochem Pharmaceutical Corporation Information
4.10.2 Tianjin Biochem Pharmaceutical Oxytocin Product Description
4.10.3 Tianjin Biochem Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2015-2020)
4.10.4 Tianjin Biochem Pharmaceutical Overview and Its Total Revenue
4.10.5 Tianjin Biochem Pharmaceutical Recent Development
5 BREAKDOWN DATA BY TYPE (2015-2026)
5.1 China Oxytocin Sales by Type (2015-2026)
5.1.1 China Oxytocin Sales by Type (2015-2020)
5.1.2 China Oxytocin Sales Forecast by Type (2021-2026)
5.2 China Oxytocin Revenue by Type (2015-2026)
5.2.1 China Oxytocin Revenue by Type (2015-2020)
5.2.2 China Oxytocin Revenue Forecast by Type (2021-2026)
5.3 Oxytocin Average Selling Price (ASP) by Type (2015-2020)
5.4 China Oxytocin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
6 OXYTOCIN UPSTREAM RAW MATERIALS AND DOWNSTREAM APPLICATION ANALYSIS
6.1 Oxytocin Industrial Chain Analysis
6.2 Oxytocin Key Raw Materials Analysis
6.2.1 Key Raw Materials Supply Analysis
6.2.2 Key Suppliers of Raw Materials
6.3 China Oxytocin Sales by Application (2015-2026)
6.3.1 China Oxytocin Sales by Application (2015-2020)
6.3.2 China Oxytocin Sales Forecast by Application (2021-2026)
6.4 China Oxytocin Revenue by Application (2015-2026)
6.4.1 China Oxytocin Revenue by Application (2015-2020)
6.4.2 China Oxytocin Revenue Forecast by Application (2021-2026)
7 CHINA OXYTOCIN PRODUCTION AND CAPACITY ANALYSIS
7.1 China Oxytocin Supply and Demand Forecast, 2015-2026
7.1.1 China Oxytocin Production Capacity and Capacity Utilization, 2015-2026
7.1.2 China Oxytocin Production, Apparent Consumption and Forecast, 2015-2026
7.1.3 China Oxytocin Production, Demand and Forecast, 2015-2026
7.1.4 China Oxytocin Production Value, 2015-2026
7.2 Oxytocin Export and Import in China
7.2.1 Oxytocin Production, Consumption, Export and Import in China, 2015-2026
7.2.2 Oxytocin Export and Import in Value in China, 2015-2026
7.2.3 China Oxytocin Source of Imports
7.2.4 China Oxytocin Export Market
7.3 China Key Local Oxytocin Manufacturers Production Capacity
7.4 China Key Local Oxytocin Manufacturers Production
7.5 China Key Local Oxytocin Manufacturers Production Value
8 SALES CHANNELS, AFFECTING FACTORS, OPPORTUNITY AND CHALLENGE ANALYSIS
8.1 China Market Oxytocin Sales Channels Analysis
8.2 Sales Channels and Marketing Strategy
8.3 China Oxytocin Development Advantages and Disadvantages
8.4 China Oxytocin Development Opportunity
8.5 China Oxytocin Market Challenge
8.6 China Local Oxytocin Manufacturers SWOT Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer